Society of Hematologic Oncology

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

SOHO 2023
Leukemia Lymphoma Myeloma MDS and MPN Videos
SOHO 2022
Myeloma Lymphoma Leukemia MDS and MPN Benign Hematology
SOHO 2021
Myeloma Cellular Therapy Solid Tumors Leukemia MDS Benign Hematology MPN Lymphoma
SOHO 2020
Basic Science Lymphoma Leukemia Myeloma MDS and MPN Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Meet The Professor Sessions Chronic Myeloid Leukemia Myeloproliferative Neoplasms Breakfast With The Expert Independent Satellite Symposium Plenary Sessions Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Acute Myeloid Leukemia Indolent B-cell Lymphoma Mantle Cell Lymphoma Aggressive B-cell Lymphoma T-cell Lymphoma Cellular Therapy Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia Session II: Myelodysplastic Syndromes Session III: Myeloproliferative Neoplasms Session IV: Acute Lymphoblastic Leukemia Session V: Acute Myeloid Leukemia Session VI: Multiple Myeloma Session VIII: Non-Hodgkin Lymphoma Session IX: Chronic Lymphocytic Leukemia Session X: Research Topics Plenary Sessions Breakfast with the Expert
Events

Playback speed

10 seconds

SOHO 2021 BRUIN Trial Update on Previously Treated CLL/SLL: Pirtobrutinib, a Next-Generation, Highly Selective, Non-covalent BTKi

By Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021) FEATURING Catherine Coombs

33 views

September 30, 2021

Comments 0

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Leukemia

SOHO 2021 Next Questions in ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

B. Shah

215 views

SOHO 2021 Next Questions in AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

H. Kantarjian

27 views

SOHO 2021 Next Questions in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. O'Brien

85 views

SOHO 2021 Next Questions in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Cortés

57 views

SOHO 2021 Update on Managing TKI Resistance in CML: New Options

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

D. Rea

17 views

SOHO 2021 Update: State-of-the-Art in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Hochhaus

18 views

SOHO 2021 Highlights on CML and Pregnancy

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

E. Abruzzese

17 views

SOHO 2021 OPTIC Primary Analysis on CP-CML: A Dose-Optimization Stud…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Cortés

68 views

SOHO 2021 Update on Treatment-Free Remission in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

E. Atallah

85 views

SOHO 2021 Case Study: Managing Cytopenias on TKI Therapy in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Apperley

14 views

SOHO 2021 Highlights on the Use of MRD in CLL: American Perspective

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Davids

379 views

SOHO 2021 Highlights on the Use of MRD in CLL: European Perspective

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

O. Al-Sawaf

12 views

SOHO 2021 Update on CLL: Molecular and Microenvironmental Basis of I…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Deaglio

9 views

SOHO 2021: Management of Infections in Patients With CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. Niemann

9 views

SOHO 2021 Debate: Do Old Prognostic Markers Still Have a Role in CLL…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

I. Ahn

12 views

SOHO 2021 Debate on Old Prognostic Markers in CLL Management: Do The…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Coutre

10 views

SOHO 2021: Approaches to Therapy of Richter's Syndrome in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

D. Rossi

19 views

SOHO 2021: New Targetable Pathways in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Danilov

13 views

SOHO 2021 BRUIN Trial Update on Previously Treated CLL/SLL: Pirtobru…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. Coombs

33 views

SOHO 2021 Update on the Management of Advanced CML: Blast Crisis

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Deininger

18 views

SOHO 2021: How Can We Improve on AML MRD Assessment by Flow Cytometry

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Freeman

15 views

SOHO 2021 Update on Menin Inhibitors in AML: What Are the Prospects?

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

E. Wang

16 views

SOHO 2021: Novel Strategies to Treat Elderly With AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

T. Kadia

132 views

SOHO 2021: Conventional Chemotherapy-Free Regimens in ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Wieduwilt

14 views

SOHO 2021 Highlights on the Approach to Ph+ ALL: From Worst to Best?

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

P. Kebriaei

128 views

SOHO 2021: Chemoresistance and Drug Profiling in ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

B. Bornhauser

10 views

SOHO 2021 Data on the Resistance to BCL-2i in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. Tam

8 views

SOHO 2021 Data on the Resistance to BTKi in CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Woyach

296 views

SOHO 2021 Highlights on Cellular Therapy for CLL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

T. Kipps

9 views

SOHO 2021 Update on the Genomically Guided Frontline Therapy in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

T. Hughes

15 views

SOHO 2021 Update on Molecular Testing of CML Patients: Between Old a…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Soverini

11 views

SOHO 2021 Highlights on the Approach to the Elderly Patients With AL…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Chiaretti

13 views

SOHO 2021 Update on Novel Transplant and Post-transplant Options in …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Logan

24 views

2021 SOHO Update on the Use of BCL2i in ALL: Targeting Apoptosis

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

W. Stock

10 views

SOHO 2021 Update on Familial Predisposition to AML: How Far Are We i…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

L. Godley

13 views

SOHO 2021: Beyond BCL2 Inhibition & Prospects for MCL1 Inhibitors an…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

M. Konopleva

15 views

SOHO 2021 Highlights on Single Cell Profiling in AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

K. Takahashi

12 views

SOHO 2021 Case Study: 1L Treatment in an Older Patient With TN-CLL W…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

N. Lamanna

11 views

SOHO 2021 Case Study: Relapse After 1L BTKi Therapy in RR-CLL Patien…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

N. Lamanna

13 views

SOHO 2021 Case Review: CLL Refractory to BTKi and to Venetoclax

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Burke

13 views

SOHO 2021 Case Review: Richter's Transformation of CLL to DLBCL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Burke

21 views

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

D. Stephens

13 views

SOHO 2021 Case Review: Optimal 1L Therapy for a Young/Fit CLL Patien…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

D. Stephens

14 views

SOHO 2021 Update on Response and Progression in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Radich

12 views

SOHO 2021 Update on the Importance of BCR-ABL Transcript Type in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

N. Cross

21 views

2021 SOHO Highlights on New Drugs and New Challenges in CML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Cortés

13 views

SOHO 2021 Updates on Hyper-CVAD in ALL: Lessons Learned and New Appr…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

E. Jabbour

17 views

SOHO 2021 Update on MRD in ALL: Techniques and Therapeutic Utility O…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

L. Muffly

61 views

SOHO 2021 Data on Novel CAR-T Constructs for ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

P. Lu

14 views

SOHO 2021 Updates on Asparaginase in Adults With ALL: Understanding …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

I. Aldoss

38 views

SOHO 2021 Highlights: Novel Approaches to T-Cell ALL

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

D. Teachey

178 views

SOHO 2021 Debate on the Optimal Time for Blinatumomab in ALL: Is It …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

R. Rau

59 views

SOHO 2021 Debate on the Optimal Time for CAR-T in Pediatric B-ALL: I…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

R. Gardner

13 views

2021 SOHO Update on Childhood ALL: The Impact of Genetic Ancestry on…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

S. Lee

14 views

2021 SOHO Update on IDH-Mutated AML: Beyond Enasidenib and Ivosideni…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. DiNardo

38 views

2021 SOHO Update on FLT3-Mutated AML: Moving Towards Cure

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Perl

42 views

2021 SOHO Update on Antibody-Based Therapy in AML: Immunotoxins and …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Fathi

22 views

SOHO 2021 New Horizons in TP53-Mutated AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

N. Daver

29 views

SOHO 2021 Debate on the Maintenance Therapy in AML: Is It Necessary?

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

F. Ravandi

20 views

2021 SOHO Debate: Is Maintenance Therapy in AML Necessary?

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Lancet

15 views

2021 SOHO Highlights on MRD in AML

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Cloos

15 views

2021 SOHO Update on Newly Diagnosed AML: Venetoclax Combined With FL…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

C. Lachowiez

24 views

SOHO 2021 Update on Algorithmic Diagnostic Approach and Spectrum of …

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

A. Ferrer

SOHO 2021 Updates on Managing CLL Patients Relapsed or Refractory to…

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

J. Brown

20 views